European Leukemia Trial Registry
Prof. Dr. Oliver Ottmann

Person Prof. Dr. Oliver Ottmann
Physician
Address
Universitätsklinikum Frankfurt/Main
Medizinische Klinik II, Hämatologie/Onkologie
Theodor-Stern Kai 7
60590 Frankfurt / Main
Tel: +49 (0)69 6301 87070
Fax: +49 (0)69 6301 4170
Email: ottmann@em.uni-frankfurt.de
Trials
ALL GMALL Imatinib Elderly-0102 Leader | Scientific Contact | Public Contact
ALL GMALL Imatinib in PH/BCR-ABL + ALL Leader | Scientific Contact | Public Contact
ALL GMALL Imatinib post SZT Leader | Scientific Contact | Public Contact
ALL GMALL Imatinib+Zometa Leader | Scientific Contact | Public Contact
ALL GMALL Imatinib-Flag-Ida Leader | Scientific Contact | Public Contact
ALL GMALL Imatinib-IFN Leader | Scientific Contact | Public Contact
ALL GMALL SCT Elderly Leader | Scientific Contact | Public Contact
ALL GMALL-Imatinib/MRD-01/01 Public Contact
ALL GRAALLPHAG06/ EWALL-PH-01 Leader | Scientific Contact | Public Contact
AML ATRA / Valproid acid Leader | Scientific Contact | Public Contact
AML Elderly Leader | Scientific Contact | Public Contact
AS703569 Leader | Scientific Contact
AURA 6202-003 Leader | Scientific Contact | Public Contact
AURA-6202-004 Leader | Scientific Contact
BEZ235 Leader | Scientific Contact
BMS CA 180 323 Leader | Public Contact
BMS CA 180 323 Leader | Public Contact
BMS CA216-002 Leader
CA180-373 Leader | Scientific Contact | Public Contact
CLBH589B2116 Leader | Scientific Contact
CLBH589B2213 Leader | Scientific Contact
CLBH589H2101 Leader
CLBH589H2101 Leader | Scientific Contact
CML AMN107 2101 Leader | Scientific Contact | Public Contact
CML AMN107 2109 Leader | Scientific Contact | Public Contact
CML AMN107 2303 Leader | Scientific Contact | Public Contact
EWALL-PH-02 Leader | Scientific Contact
GMALL-PH-01 Leader
JAKARTA Scientific Contact
LAQ824 Leader | Scientific Contact | Public Contact
LBH589 Leader | Scientific Contact | Public Contact
ALL GMALL Imatinib Elderly-0102 Study Physician
ALL GMALL Imatinib in PH/BCR-ABL + ALL Study Physician
ALL GMALL Imatinib+Zometa Study Physician
ALL GMALL Imatinib-Flag-Ida Study Physician
ALL GMALL Imatinib-IFN Study Physician
ALL GMALL SCT Elderly Study Physician
ALL GRAALLPHAG06/ EWALL-PH-01 principal investigator
AURA 6202-003 principal investigator
BMS CA216-002 principal investigator
CLBH589B2116 principal investigator
CLBH589H2101 principal investigator
CLBH589H2101 principal investigator
CML AMN107 2109 principal investigator
CML AMN107 2303 principal investigator
CML CSTI571A-DE-01 principal investigator
CML Dasatinib in CML chronic phase General Contact Person
CML Dasatinib in CML progressive phase / Ph+ ALL General Contact Person
CML accelerated phase principal investigator
CML chronic phase principal investigator
LBH589 Study Physician
MEK 111759 Principal Investigator
MEK 111759 principal investigator
TARGET (CAMN107 ADE04) principal investigator


all Persons
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org